| Clinical Result of Consecutive
65 Cases of Minimally Invasive Direct Coronary Artery Bypass
Grafting |
(Department of Cardiovascular Surgery, Kochi Municipal
Hospital, Kochi, Japan)
| Tomoaki Suzuki |
Manabu Okabe |
Mitsuteru Handa |
| Atsushi Takamori |
Fuyuhiko Yasuda |
Yuo Kanamori |
|
Minimally invasive direct coronary
artery bypass grafting (MIDCAB) has been performed in some institutions
and mid-term results have been reported. However, because of
its technical difficulty, the procedure has not been gaining
acceptance among cardiovascular surgeons. We report the clinical
results of our MIDCAB series and describe the effect and role
of the MIDCAB in the therapy of ischemic heart disease. From
May 1999 through May 2002, 65 patients (age 29 to 90 years) underwent
MIDCAB via a small left thoracotomy. Postoperative angiography
was performed before discharge in all patients. No conversions
to sternotomy were necessary. There were no operative, hospital
or mid-term mortalities, nor were these any major complications,
including myocardial infarction, stroke, respiratory failure,
and other organ failure. Wound infection occurred in 1 patient.
No graft occlusion was seen. Graft stenosis was seen in only
1 patient. The graft patency rate was 98.5% (66/67). Postoperative
cardiac events included 2 incidents of angina, and 4 of atrial
fibrillation. There were no incidents of congestive heart failure.
MIDCAB is a safe and less-invasive operation. According to our
clinical results, MIDCAB is an alternative to conventional coronary
artery bypass grafting for selected patients, especially for
those at high risk.
Jpn. J. Cardiovasc. Surg. 32: 272 -275 (2003) |
|
